NCT01866527

Brief Summary

Early treatment is considered essential for developmental dysplasia of the hip (DDH), but the choice of screening strategy is debated. The investigators evaluated the effect of a selective ultrasound (US) screening programme. All infants born in a defined region during 1991-2006 with increased risk of DDH, i.e. clinical hip instability, breech presentation, congenital foot deformities or a family history of DDH, were subjected to US screening at age one to three days. Severe sonographic dysplasia and/or dislocatable/dislocated hips were treated with abduction splints. Mild dysplasia and/or pathological instability, i.e. not dislocatable/dislocated hips were followed clinically and sonographically until spontaneous resolution, or until treatment became necessary. The minimum observation period was 5,5 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81,564

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1991

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1991

Completed
21.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 31, 2013

Completed
Last Updated

May 31, 2013

Status Verified

May 1, 2013

Enrollment Period

21.6 years

First QC Date

May 23, 2013

Last Update Submit

May 28, 2013

Conditions

Keywords

Developmental dysplasia of the hip,DDH,avascular necrosis,late detected cases

Outcome Measures

Primary Outcomes (1)

  • late dislocated or subluxated hips

    late detected after 1 month of life, requiring treatment

    first 5 years of life

Secondary Outcomes (4)

  • Number of participants who receive ultrasound follow-up for 6 weeks or more

    first months of life

  • early treatment

    first months of life

  • first surgical treatment

    first five years of life

  • avascular necrosis of femoral head

    first five years of life

Study Arms (1)

all newborns born 1991-2006

all newborns born 1991-2006

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All infants born at the maternity unit at Haukeland University Hospital from January 1991 through December 2006 were included. The hospital provides the only delivery unit for the city and suburbs of Bergen and a large rural area within the Hordaland County. It serves a population of approximately 400 000 inhabitants, predominantly ethnic Norwegians. The annual birth rates varied from 4723 to 6010. Minimum observation time was 5,5 years.

You may qualify if:

  • born at Haukeland University hospital January 1991-December 2006

You may not qualify if:

  • Children with DDH due to neuromuscular syndromes were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Paediatric section, Radiology department, Haukeland University hospital, Bergen, Norway

Bergen, 5021, Norway

Location

MeSH Terms

Conditions

Developmental Dysplasia of the HipOsteonecrosis

Condition Hierarchy (Ancestors)

Hip DislocationJoint DislocationsJoint DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karen Rosendahl, PhD

    Paediatric Section, Department of Radiology, Haukeland University hospital, Bergen

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 23, 2013

First Posted

May 31, 2013

Study Start

January 1, 1991

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

May 31, 2013

Record last verified: 2013-05

Locations